A case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llac124
Abstract: The risk of developing malignancies including cutaneous T-cell lymphoma with use of Janus kinase inhibitors is of concern. Here, we describe a case of Sézary syndrome in a patient during treatment with baricitinib for seronegative… read more here.
Keywords: baricitinib seronegative; zary syndrome; syndrome patient; treatment baricitinib ... See more keywords